1. Home
  2. OPK vs HUMA Comparison

OPK vs HUMA Comparison

Compare OPK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • HUMA
  • Stock Information
  • Founded
  • OPK 2007
  • HUMA 2004
  • Country
  • OPK United States
  • HUMA United States
  • Employees
  • OPK N/A
  • HUMA N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPK Health Care
  • HUMA Health Care
  • Exchange
  • OPK Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • OPK N/A
  • HUMA 367.6M
  • IPO Year
  • OPK 1995
  • HUMA N/A
  • Fundamental
  • Price
  • OPK $1.35
  • HUMA $2.32
  • Analyst Decision
  • OPK Buy
  • HUMA Strong Buy
  • Analyst Count
  • OPK 4
  • HUMA 7
  • Target Price
  • OPK $2.75
  • HUMA $13.00
  • AVG Volume (30 Days)
  • OPK 3.5M
  • HUMA 3.2M
  • Earning Date
  • OPK 08-06-2025
  • HUMA 08-12-2025
  • Dividend Yield
  • OPK N/A
  • HUMA N/A
  • EPS Growth
  • OPK N/A
  • HUMA N/A
  • EPS
  • OPK N/A
  • HUMA N/A
  • Revenue
  • OPK $689,408,000.00
  • HUMA $517,000.00
  • Revenue This Year
  • OPK N/A
  • HUMA N/A
  • Revenue Next Year
  • OPK $7.80
  • HUMA $896.45
  • P/E Ratio
  • OPK N/A
  • HUMA N/A
  • Revenue Growth
  • OPK N/A
  • HUMA N/A
  • 52 Week Low
  • OPK $1.19
  • HUMA $1.15
  • 52 Week High
  • OPK $2.04
  • HUMA $9.79
  • Technical
  • Relative Strength Index (RSI)
  • OPK 56.84
  • HUMA 50.18
  • Support Level
  • OPK $1.26
  • HUMA $2.08
  • Resistance Level
  • OPK $1.36
  • HUMA $2.40
  • Average True Range (ATR)
  • OPK 0.04
  • HUMA 0.14
  • MACD
  • OPK 0.01
  • HUMA -0.03
  • Stochastic Oscillator
  • OPK 92.31
  • HUMA 52.63

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: